JNJ Stock: Johnson & Johnson Stock Price, Analysis & Insights
Get live jnj stock price $202.51, comprehensive Johnson & Johnson stock analysis, charts, news, and expert forecast. Real-time jnj stock data and investment insights.
Loading chart...
Company Overview
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Company Information
- CEO
- Joaquin Duato
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 138100
Contact Information
- Website
- https://www.jnj.com
- Address
- One Johnson & Johnson Plaza
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Market leader with 487.9 billion market capitalization
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 19.6)
✓ Lower volatility stock (Beta: 0.36) may provide portfolio stability
Business Model & Strategy
Johnson & Johnson operates in the Drug Manufacturers - General industry, focusing on medical services, pharmaceutical development, and healthcare delivery. As a large-cap company, Johnson & Johnson benefits from scale advantages, market presence, and established operations. Under the leadership of CEO Joaquin Duato, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Drug Manufacturers - General model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Johnson & Johnson competes in the Drug Manufacturers - General within the broader Healthcare. With 487.9 billion in market capitalization, the company is positioned as a market leader in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the New York Stock Exchange, Johnson & Johnson provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Johnson & Johnson should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Johnson & Johnson shareholders
- ⚠Market volatility can significantly impact stock price, especially for large-cap equities
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Johnson & Johnson
- ⚠Investors should consider how Johnson & Johnson fits within their overall portfolio allocation
Market Cap
487.91B
P/E Ratio
19.55
Beta
0.36
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 487.91B market capitalization
- Trading Volume: 14.68M shares traded today
- Price Range: 52-week range of $140.68 - $203.48
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for Johnson & Johnson
Johnson & Johnson (JNJ) operates in the Drug Manufacturers - General industry within the Healthcare sector. With a current market capitalization of 487.91B, the company represents a significant player in its market. The stock is currently trading at $202.51 with a positivedaily change of 1.25%.
The company's 138100 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 19.55, beta of 0.36, and 52-week price range from $140.68 to $203.48when evaluating investment opportunities.
Why Invest in Johnson & Johnson?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under Joaquin Duato
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.